Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Elisa A. Rozeman, Esmée P. Hoefsmit, Irene L. M. Reijers, Robyn P.M. Saw, Judith M. Versluis, Oscar Krijgsman, Petros Dimitriadis, Karolina Sikorska, Bart A. van de Wiel, Hanna Eriksson,

Nature Medicine · 2021 · 337 citations · 35 references

DOIFull text

Open access

Concepts

References

35